Company research
AMERICAN BIO MEDICA CORP
CIK 896747Updated Nov 16, 2026
Securities
Historical securities (1)
ABMC · OTC · equity · closed Jul 3, 2025ABMC price & chart
Historical security
This listing closed Jul 3, 2025. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2022 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 1,269,000Source | 1,883,000Source | 1,926,000Source | 2,078,000Source |
| Property, Plant and Equipment, NetUSD | 466,000Source | 517,000Source | 576,000Source | 644,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 34,000Source | 115,000Source | 98,000Source | 4,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 82,000Source | 323,000Source | 407,000Source | 370,000Source |
| Inventory, NetUSD | 379,000Source | 443,000Source | 536,000Source | 810,000Source |
| Assets, CurrentUSD | 769,000Source | 1,340,000Source | 1,180,000Source | 1,227,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 72,000Source | 24,000Source | 104,000Source | 6,000Source |
| Operating Lease, Right-of-Use AssetUSD | 13,000Source | 35,000Source | 41,000Source | 73,000Source |
| Other Assets, NoncurrentUSD | 21,000Source | 21,000Source | 21,000Source | 21,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 3,608,000Source | 2,827,000Source | 3,182,000Source | 2,868,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 481,000Source | 476,000Source | 377,000Source | 327,000Source |
| Additional Paid in CapitalUSD | 22,403,000Source | 23,393,000Source | 21,717,000Source | 21,437,000Source |
| Retained Earnings (Accumulated Deficit)USD | -25,223,000Source | -23,813,000Source | -23,350,000Source | -22,554,000Source |
| Stockholders' Equity Attributable to ParentUSD | -2,339,000Source | -944,000Source | -1,256,000Source | -790,000Source |
| Liabilities and EquityUSD | 1,269,000Source | 1,883,000Source | 1,926,000Source | 2,078,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 3,602,000Source | 2,824,000Source | 2,021,000Source | 1,687,000Source |
| Operating Lease, Liability, CurrentUSD | 4,000Source | 35,000Source | 33,000Source | 34,000Source |
| Accounts Payable, CurrentUSD | 760,000Source | 682,000Source | 577,000Source | 652,000Source |
| Operating Lease, Liability, NoncurrentUSD | 6,000Source | 3,000Source | 41,000Source | 73,000Source |
| Additional Financial Items | ||||
| Long-term DebtUSD | 2,230,000Source | 1,543,000Source | — | — |
| Long-term Debt, Current MaturitiesUSD | 2,230,000Source | 1,543,000Source | 684,000Source | 354,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | — | — | 1,120,000Source | 1,125,000Source |
cash flow · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | 1,410,000Source | — | — | — |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | — | — | 79,000Source | 81,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 0Source | 0Source | 2,000Source | 6,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | -242,000Source | 103,000Source | 40,000Source | -84,000Source |
| Increase (Decrease) in InventoriesUSD | -107,000Source | 92,000Source | -117,000Source | -113,000Source |
| Increase (Decrease) in Accounts PayableUSD | 78,000Source | 105,000Source | -75,000Source | 293,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -768,000Source | -673,000Source | -483,000Source | — |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | 0Source | -4,000Source | — |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | 0Source | 4,000Source | — |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 687,000Source | 690,000Source | 581,000Source | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 34,000Source | — | — | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 34,000Source | — | — | — |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 180,000Source | 190,000Source | 152,000Source | 155,000Source |
| Income Taxes Paid, NetUSD | 37,000Source | 2,000Source | 2,000Source | — |
| Additional Financial Items | ||||
| Amortization of Debt Issuance CostsUSD | — | 0Source | 17,000Source | 108,000Source |
| DepreciationUSD | 51,000Source | 60,000Source | 71,000Source | 74,000Source |
| Gain (Loss) on Disposition of Other AssetsUSD | 3,000,000Source | — | — | — |
| Gain (Loss) on Extinguishment of DebtUSD | 0Source | 335,000Source | — | — |
| General and Administrative ExpenseUSD | 917,000Source | 1,338,000Source | 1,276,000Source | 1,236,000Source |
| Impairment of Intangible Assets (Excluding Goodwill)USD | 0Source | — | — | — |
| Income Tax Expense (Benefit)USD | 2,000Source | 2,000Source | 2,000Source | -5,000Source |
| Net Income (Loss) Attributable to ParentUSD | -1,410,000Source | -463,000Source | -796,000Source | -681,000Source |
| Operating ExpensesUSD | 1,139,000Source | 1,727,000Source | 1,859,000Source | 1,777,000Source |
| Operating Lease, ExpenseUSD | 3,000Source | — | — | — |
| Other Nonoperating Income (Expense)USD | -166,000Source | 718,000Source | -173,000Source | -93,000Source |
income statement · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Total RevenueUSD | 913,000Source | 2,218,000Source | 4,147,000Source | 3,655,000Source |
| Cost of Goods and Services Sold | — | — | — | — |
| Operating Income (Loss)USD | -1,242,000Source | -1,179,000Source | -621,000Source | -593,000Source |
| Other Nonoperating Income (Expense)USD | -166,000Source | 718,000Source | -173,000Source | -93,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -1,408,000Source | — | — | — |
| Income Tax Expense (Benefit)USD | 2,000Source | 2,000Source | 2,000Source | -5,000Source |
| Net Income (Loss) Attributable to ParentUSD | -1,410,000Source | -463,000Source | -796,000Source | -681,000Source |
| Earnings Per Share, BasicUSD per share | — | -0.01Source | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | — | 42,761,065Source | — | — |
| Additional Financial Items | ||||
| Depreciation, Depletion and Amortization, NonproductionUSD | 51,000Source | 68,000Source | — | — |
| General and Administrative ExpenseUSD | 917,000Source | 1,338,000Source | 1,276,000Source | 1,236,000Source |
| Gross ProfitUSD | -103,000Source | 548,000Source | 1,238,000Source | 1,184,000Source |
| Interest ExpenseUSD | 194,000Source | 194,000Source | 175,000Source | 265,000Source |
| Interest Income, OtherUSD | 3,000Source | — | — | — |
| Operating ExpensesUSD | 1,139,000Source | 1,727,000Source | 1,859,000Source | 1,777,000Source |
| Operating Lease, ExpenseUSD | 3,000Source | — | — | — |
| Research and Development ExpenseUSD | 85,000Source | 85,000Source | 90,000Source | 82,000Source |
| Selling and Marketing ExpenseUSD | 137,000Source | 304,000Source | 493,000Source | 459,000Source |